A Case of Primary Influenza B Pneumonia in Lupus Nephritis Patient on Immunosuppressive Treatment
Author(s) -
So-Yeon Park,
Jae Gon Lee,
Wan-Sik Uhm,
SangCheol Bae,
YoonKyoung Sung
Publication year - 2011
Publication title -
journal of rheumatic diseases
Language(s) - English
Resource type - Journals
eISSN - 2093-940X
pISSN - 2233-4718
DOI - 10.4078/jrd.2011.18.3.193
Subject(s) - medicine , lupus nephritis , pneumonia , pneumonitis , cyclophosphamide , myocarditis , immunology , atypical pneumonia , lung , systemic lupus erythematosus , oseltamivir , pathology , infectious disease (medical specialty) , disease , chemotherapy , covid-19
Infectious diseases, particularly pneumonia, remain a major cause of morbidity and mortality in patients with systemic lupus erythematous (SLE), accounting for 30∼50% of all death. Because infection appears in various forms in lupus patients, early detection and appropriate treatment is very important. In the case of diffuse infiltration in the whole lung field, we should make a differential diagnosis with drug-induced pneumonitis, interstitial lung disease and pneumonia caused by atypical microorganism infection. In particular, in case of atypical microorganism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom